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ABSTRACT 26 
Increasing antibiotic resistant hospital-acquired infections and limited new antibiotic 27 
discovery are jeopardizing human health at global scales, although how hospitals themselves fuel 28 
AMR in the wider environment is largely unknown. Antibiotic resistance (AR) from hospitals in 29 
countries like India is potentially problematic because of high antibiotic use, overcrowding, and 30 
inadequate wastewater containment. Here we quantified fecal coliforms (FC), carbapenem-31 
resistant Enterobacteriaceae (CRE), blaNDM-1, and selected extended-spectrum β-lactam (ESBL) 32 
resistant bacteria and genes in 12 hospital wastewater outfalls and five background sewer drains 33 
across New Delhi over two seasons. Hospital wastewaters had up to nine orders of magnitude 34 
greater concentrations of CRE bacteria and blaNDM-1 than local sewers (depending on the 35 
hospital), implying hospitals contribute high concentrations of AR relative to community sources 36 
in Delhi, especially during the winter. Significant correlations were found between FC levels (a 37 
fecal indictor), and CRE (r =0.924; p =0.005), blaNDM-1 (r=0.934, p=0.009), and ESBL-resistant 38 
bacteria (r=0.913, p=0.010) levels across hospital wastewaters, respectively, imp-lying elevated 39 
CRE and blaNDM-1 are of patient origin. However, of greater importance to global health, 40 
microbial culturing found 18 to 41% of wastewater CRE isolates (n =1447) were on the WHO 41 
“critical pathogen” list in urgent need of new antibiotics, and 55% of CRE isolates from larger 42 
hospitals carried at least one blaNDM-1 gene. Wastewater releases from New Delhi hospitals may 43 
pose a greater AR exposure risk to residents than believed, implying in-hospital antibiotic use 44 
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Introduction 50 
Antibiotic resistance (AR) is a global public health concern. In fact, emergence of resistant 51 
and untreatable phenotypes in hospital-acquired infections and limited new antibiotic discovery 52 
is threatening return to a pre-antibiotic era1,2. Wastewater releases from hospitals contribute to 53 
this problem. Antibiotics are routinely used to treat infections, but treatment results in antibiotic 54 
residues, and resistant bacteria (ARB) and genes (ARGs) being excreted in patient wastes, 55 
entering hospital wastewater systems3. Waste-born nosocomial and commensal ARB carrying 56 
ARGs are then released to the wider environment into sewers, exposing individuals away from 57 
hospitals to AR of hospital origination. Although many gut flora die-off upon release to sewers, 58 
they can exchange ARGs to environmental strains via horizontal gene transfer (HGT) on 59 
plasmids, transposons and integrons4,5. As such, hospital antibiotic use can lead to wider ARB 60 
and ARG dissemination via wastewater, becoming a potential health concern, especially in parts 61 
of world with inadequate wastewater treatment and community sanitation. 62 
In emerging countries, such as India, this problem is particularly acute. Local domestic 63 
wastewater treatment is often not adequate, and clean, safe water is not assured6. As an example, 64 
only ~40% of wastewater in New Delhi is treated7,8; therefore, ARB and ARGs released in 65 
hospital wastes to community sewer drains pose a particular exposure risk due to the inadequate 66 
urban infrastructure. This is especially key relative to hospitals in Delhi because antibiotic use is 67 
often high; overcrowding is common9,10; and reliable internal wastewater management is often 68 
lacking. As such, hospital wastewater releases may particularly contribute to AR spread and 69 
exposures in places like India, especially to the very poor who frequently reside near open 70 
drains. For the above reasons, AR infections are more common, causing higher per patient 71 
treatment costs, prolonged morbidity, and increased mortality rates9–13 due to nosocomial 72 
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transmission of multidrug-resistant (MDR) organisms, including Streptococcus pneumoniae14, 73 
Mycobacterium tuberculosis
15
, Salmonella sp., Shigella16, and Vibrio cholera17. ARB and ARGs 74 
released in hospital wastes pose a huge challenge in the emerging world18 as was suggested by 75 
the World Health Organization19 and other recent reports20. 76 
India is the largest consumer of antibiotics for human use in the world10, and β-lactam 77 
antibiotics are among the most common drugs used in India, including carbapenems21. It is not 78 
surprising, therefore, first detection of blaNDM-1 was in a Klebsiella pneumonia isolate from an 79 
Indian hospital patient in 200822. blaNDM-1 codes for a metallo-beta-lactamase (NDM-1) that can 80 
confer MDR23. After initial clinical detection, blaNDM-1 was soon found in Delhi surface waters 81 
(in 2010), and now is present in >100 countries24–26, including in strains functionally resistant to 82 
all antibiotics, including colistin26,27. However, blaNDM-1 is only one example of hospital-born 83 
AR spread via wastes. Extended spectrum β-lactamase (ESBL) Enterobacteriaceae were 84 
detected in Lebanese hospital wastes28, MDR E. coli in Malaysian hospital wastes (including 85 
blaNDM-1)
29, and in Spanish hospital wastewater bacteria30 carrying class 131 or class 332 integrons 86 
Overall, evidence show hospital wastewaters are a potentially important source of AR to the 87 
environment, especially in places like New Delhi. However, little is known about how hospital 88 
wastes impact the nature and abundance of ARB and ARGs released to the environment, 89 
especially how hospital wastewater levels compare with background levels in community 90 
sewage. To address this question, ARB/ARGs from 12 hospital waste outfalls and five sewer 91 
drains in New Delhi were quantified and characterized over two seasons. Focus here was on 92 
carbapenem-resistant Enterobacteriaceae (CRE), blaNDM-1, and selected ESBL ARGs and ARBs 93 
to guide mitigation efforts in India, although results have global implications because extreme 94 
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resistant phenotypes in places like India have the potential to spread globally via international 95 
travel and other pathways.  96 
Materials and Methods  97 
Study sites and samples collection: Wastewater samples were collected in triplicate from 98 
sewage outfalls to community drains from 12 hospitals in New Delhi in February/March 99 
(“winter”) and May/June (“summer”) 2014. The hospitals have been anonymised for 100 
confidentiality, but size and other data are provided in Table S1 (Supporting Information; SI), 101 
which are the best available. The hospitals were chosen based upon various criteria, including: 102 
public versus private management, bed capacity, location, and medical approaches, including 103 
allopathic and unani medicine. Most of the hospitals surveyed here are general public hospitals 104 
(government ) that use both conventional and allopathic approaches in treatment. In parallel to 105 
hospital wastewater sampling, replicate wastewater samples were collected from five sewer 106 
drains in New Delhi to contrast community versus hospital sources of AR to the environment. 107 
Only drains without hospitals in their catchments were sampled, including: the Najafgarh Drain 108 
(28◦31’25’’N 76◦54’51’’E), Palam Drain (28◦32’25’’N 77◦01’10’’E), Bawana Escape Drain 109 
(28◦75’44’’N 77◦18’28’’E), Ali Drain (28◦30’32’’N 77◦18’50’’E) and Sarita Vihar Drain 110 
(28◦31’30’’N 77◦19’12’’E). 111 
Both hospital and drain wastewater sampling was performed in the summer and winter to 112 
assess seasonal differences, such as temperature and drug use trends in each season33. Specific 113 
samples were collected in sterile 500-mL containers, returned to the laboratory on ice in coolers, 114 
and stored at 4°C for further analysis. Microbial culturing was performed within 12 hours of 115 
sampling. To quantify wastewater conditions, temperature, pH, total dissolved solids (TDS) and 116 
conductivity were measured in-situ using hand-held probes (detailed in Table S2).  117 
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 118 
Microbial Culturing of coliforms and ARB:  Microbial culturing was performed to quantify 119 
the abundance of fecal coliform (FC), total coliform (TC), ESBL-resistant bacteria (ESBL) and 120 
CRE using selective media, and to identify putative pathogens in hospital and drain wastewaters. 121 
Prior to plating, samples were serially diluted in sterile phosphate buffer solution (PBS), and then 122 
were plated at different dilutions in triplicate on M-FC Agar (FC), Rapid HiColiform Agar (TC), 123 
HiCrome ESBL Agar (ESBL ARB), HiCrome KPC Agar (to capture CRE ARB). The 124 
HiColiform, HiCrome ESBL and HiCrome KPC plates were incubated at 37˚C for 24 h, whereas 125 
M-FC plates were incubated at 45˚C for 24 h.  126 
Phenotypically-resistant isolates from hospital wastewaters (only) were randomly selected 127 
from CRE (n = 1447) and ESBL (n = 1200) plates, and DNA extracted using the FastDNA Spin 128 
kit for Soil (MP Biomedicals, USA), according to manufacturer’s instructions. Isolated DNA 129 
was amplified using bacterial 338F and 1046R primers using conditions summarised in Table S3. 130 
Conserved 16S-rRNA gene sequences (per isolate) were analyzed using Sanger sequencing and 131 
identified by BLAST. Isolate identities were verified using Biochemical Test kits (Himedia, 132 
India). DNA from all the isolates was amplified using NDM-1-F and NDM-1-R to verify the 133 
presence or absence of blaNDM-1 in each isolate, using conditions summarized in Table S3.  134 
  135 
Quantification of selected ARGs and MGE genes using quantitative PCR (qPCR): Samples 136 
for DNA extraction were either directly filtered through sterile 0.22-µm membrane disc filters 137 
(Pall Life Science, USA) or pelleted by centrifugation at 13,000 rpm for 30 mins. Subsequent 138 
DNA extraction employed the FastDNA Spin kit for Soils (MP Biomedicals, USA). Extracted 139 
DNA was stored at -20◦C prior to subsequent qPCR analysis. Prior to qPCR, DNA samples were 140 
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diluted (1:100) with nuclease free water to minimise background interferences of the qPCR 141 
reactions. Four ARGs (blaTEM, blaOXA, blaCTX, blaNDM-1), the integrase gene for class one 142 
integrons (int1), and 16S-rRNA gene were quantified using qPCR. All reactions were performed 143 
in triplicate using the BioRad CFX C1000 System (BioRad, Hercules, CA USA). All runs were 144 
performed with positive standards and negative controls. Standards probe target DNA cloned 145 
into plasmids at different dilutions, whereas negative controls were nuclease-free water. Sample 146 
preparations for each gene and programs used for qPCRs are summarised in Table S3. 147 
 148 
Data Analysis: Two types of statistical tests were used; bivariate correlation analysis between 149 
individual measured parameters in wastewater samples, and two-sample tests comparing 150 
differences according to hospital size and season. For analyses here, small and large hospitals 151 
were defined by estimated patient admissions. As background, many hospitals in India admit 152 
many more patients than their listed bed capacity, including hospitals within this study. 153 
Therefore, for hospital size comparisons, the 12 hospitals were sub-divided into two groups of 154 
six with “small” hospitals having admissions of between 150 to 691 patients and large hospitals 155 
having admission from 1950 to 7270 (see SI for details). 156 
All data analyses were performed using Excel 2007 (Microsoft Office 2007, Microsoft Corp, 157 
USA) and SPSS ver. 19.0 (IBM Inc, USA). Bivariate correlation analysis was performed using 158 
the Spearman’s non-parametric method to obtain correlation coefficients (r) and p-values. Paired 159 
sample t-tests were used to compare hospital sizes or seasons. All data were log-transformed 160 
before analysis; statistical significance was defined by 95% confidence intervals (p < 0.05). 161 
 162 
 163 
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Result and Discussion 164 
Carbapenem- and ESBL-resistant gram-negative pathogens in hospital wastewaters are a 165 
health concern in places like New Delhi due to an insufficient urban wastewater infrastructure. 166 
Although nominal wastewater flows from hospitals are small compared to the wider community 167 
(Table S4), hospitals are major points of antibiotic use and release patient wastes containing a 168 
wide range of AR strains. Therefore, knowing and quantifying bacterial and other constituents in 169 
hospital waste streams, including AR pathogens, is critical for reducing wider dissemination and 170 
impact of hospital-originated infectious agents.   171 
Within this context, summer and winter samples were collected from wastewater outfalls of 172 
12 hospitals across New Delhi just prior to entry into community sewage drains. TC, FC, ESBL-173 
resistant, and CRE abundances; selected ESBL- (blaCTX, blaOXA, blaTEM) and CRE-related 174 
(blaNDM-1) ARGs; and int1 genes (as a reflection of HGT) were quantified and sorted according 175 
to season (summarised in Tables S5 and S6) and other factors. Bivariate correlation analysis was 176 
performed on all data, and significant positive correlations were found between FC levels, and 177 
CRE (r = 0.924; p = 0.005), ESBL-resistant bacteria (r = 0.913, p = 0.010), TC (r = 0.921, p = 178 
0.008), and blaNDM-1 gene (r = 0.934, p = 0.009) concentrations in hospital wastewaters across 179 
the city (see Figure 1). FC levels also significantly correlated with int1 levels (r = 0.77, p = 0.04; 180 
see Figure S2), and with blaCTX, blaOXA, and blaTEM abundances among samples, but int1 did not 181 
significantly correlate with blaNDM-1 (p = 0.25). Overall, data show a close association between 182 
fecal bacterial levels in hospital wastewaters, and levels of CRE and ESBL-resistance isolates 183 
and genes, which are released into the environment. 184 
To better understand AR release patterns, wastewater data were segregated for each hospital 185 
per sampling season (see Figure 2, and Tables S5 and S6). Although not always statistically 186 
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significant, FC, CRE and ESBL-resistant bacterial abundances, and blaNDM-1 and int1 187 
concentrations were always higher in hospital wastewaters in winter samples. Seasonal 188 
differences were greatest for blaNDM-1 abundances, which were three to nine orders of magnitude 189 
higher in the winter versus summer. Parallel hospital antibiotic use data was not available 190 
(functionally impossible to obtain in India), but seasonal differences almost certainly relate to 191 
differences in winter versus summer antibiotic use due to higher levels of infectious disease in 192 
the winter33. Abundances of CRE also were higher in the winter, but differences between seasons 193 
were not as profound. This is possibly explained by individual phenotypes carrying multiple 194 
blaNDM-1 genes, which is common in extreme resistant phenotypes
34. Overall, results suggest 195 
greater exposures to blaNDM-1 exist in the winter from hospital wastes, which should be 196 
considered in public health AR risk assessments.        197 
To further explain differences in blaNDM-1, other factors were examined. Inspection of AR 198 
data among hospitals hinted size may play a role in disproportionately higher releases in some 199 
hospitals. Therefore, ARG and ARB hospital wastewater data were sorted according to hospital 200 
size (i.e., small = 150-691 admissions, large = 1950-7270 admissions), and larger hospitals were 201 
found to release significantly higher concentrations of FC, CRE and blaNDM-1 on a mass-per-202 
wastewater volume basis (see Figure 3). Paired t-test analysis shows FC (p = 0.046), CRE 203 
phenotypes  (p= 0.009) and blaNDM-1 (p=0.009) (and also blaCTX, p=0.020; see SI) all were 204 
significantly higher in larger versus smaller hospitals. ESBL-resistant phenotypes (p = 0.065), 205 
blaOXA (p = 0.105) and blaTEM (p = 0.139) also showed increasing trends with hospital size.  206 
A “hospital size” effect has been observed before in Sub-Saharan African hospitals, where 207 
larger hospitals contributed higher bacterial loads in their wastewaters compared with smaller 208 
hospitals35, although no explanations were provided. It was initially suspected here overcrowding 209 
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in larger hospitals might explain this trend, with hospitals H1, H2, H5, H6 and H7 (all of which 210 
are large) reporting admittance rates three to four times their bed capacity (see Table S1). 211 
However, many hospitals in India over admit. Therefore, differences between these five and the 212 
other hospitals are not definitive because, if a hospital does not report overcrowding, it not does 213 
mean overcrowding does not exist. Regardless, mean blaNDM-1 levels in wastewater from H1, H2, 214 
H5, H6 and H7 were significantly higher than the other seven hospitals (i.e., 11.29 ± 2.11 versus 215 
8.87 ± 2.15 log (copy number/mL)), implying overcrowding may be important, although more 216 
work is needed to verify this speculation.  217 
To place hospital wastewater AR data into a relative exposure context, five complimentary 218 
urban sewer drains in catchments without hospitals (to avoid bias) were sampled to quantity and 219 
contrast AR levels in “typical” Delhi community wastes (see Tables S7 and S8 for individual 220 
drain data). Significantly higher levels of TC, FC, ESBL-resistant, and CRE strains were present 221 
in hospital versus community wastes (p < 0.01 based on paired t-tests) and, with one exception, 222 
all ARGs assayed were significantly higher in the hospital wastes (p < 0.02). Of particular note, 223 
however, is the huge difference in blaNDM-1 levels between hospital and community wastes in the 224 
winter; almost nine orders of magnitude greater. Given blaNDM-1 levels significantly correlate 225 
with 16S-rRNA gene levels in the hospital wastewaters (see Figure S3; ~2.3% of 16S-rRNA 226 
genes),  data indicated particularly high levels of blaNDM-1 per cell (i.e., 16S-rRNA) are being 227 
released from hospitals, especially compared with blaNDM-1 in the community drains.  228 
To place these ARG data into a medical context, extensive microbial culturing and isolation 229 
was performed to identify specific CRE and ESBL-resistant in the hospital wastes. In large 230 
hospital wastewaters, 953 CRE (Figure 4) and 748 ESBL-resistant (Figure S4) strains were 231 
identified, whereas 494 and 452 CRE and ESBL-resistant isolates, respectively, were identified 232 
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in the small hospitals. Klebsiella pnemoniae (26%), Pseudomonas putida (19%) and Klebsiella 233 
pneumonia subsp. pneumonia (17%) were the most common CRE isolates in wastes from the 234 
large hospitals, whereas Acintobacter baumannii (25%) and Klebsiella pneumonia (14%) were 235 
the predominant CRE phenotypes in the smaller hospitals (accession numbers are provided for 236 
isolates in Table S9). In terms of ESBL-resistant isolates, E.coli (26%) was predominant in the 237 
larger hospitals, whereas Pseudomonas putida (25%) was dominant in smaller hospitals. Further 238 
genetic characterisation of the isolates showed 55% of CRE isolates from large hospitals and 239 
27% from small hospitals carried at least one blaNDM-1 gene; i.e., DNA from each isolate was 240 
amplified (using NDM-1-F and NDM-1-R) and amplicons sequenced, and relative blaNDM-1 241 
prevalence was verified. The most common carriers of blaNDM-1 were Klebsiella pnemoniae, E. 242 
coli, Acintobacter baumannii and Pseudomonas putida. Although these observations are not 243 
statistical, they indicate consequential carriage of blaNDM-1 in medically-relevant strains are being 244 
released to the wider environment in hospital wastewaters.  245 
Of particular importance from a global health perspective is the high number of CRE 246 
isolates in Delhi hospital wastewaters on the WHO pathogen list in urgent need of new 247 
therapeutic options. The WHO recently published a list of “priority pathogens” in critical need of 248 
new antibiotics36, which include carbapenem-resistant Acinetobacter baummanii, Pseudomonas 249 
aeruginosa, and ESBL-producing Enterobacteriaceae. Forty-one percent and 18% of our CRE 250 
isolates from small and large hospital wastewaters, respectively, are on the “critical” list, 251 
implying large numbers of functionally untreatable pathogens are being released to surface 252 
waters from New Delhi hospitals. Given the warm climate, such strains readily spread through 253 
the open drains, exposing millions of people to serious infectious disease. 254 
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Wider implications of these observations are not yet known. Nosocomial infections are a 255 
major cause of morbidity and mortality37, and are a major challenge for public safety. Infections 256 
caused by gram-negative bacteria, such as has been detected and isolated here, are of particular 257 
concern since such microbes can be efficient in exchanging ARGs, including single genes (e.g., 258 
blaNDM-1) that confer MDR to antibiotics. A recent report from United States highlighted that in 259 
ICUs these gram-negative bacteria are accountable for more than 70% of the nosocomial 260 
infections (predominately ventilator-associated pneumonia and urinary tract infection), and 261 
similar statistics have been reported from other parts of the world38,39. In 2002, the estimated 262 
number of nosocomial infections in U.S. was about 1.7 million and the number of deaths was 263 
estimated at ~99,000. Of these, 80% of deaths were due to hospital acquired pneumonia (36%), 264 
bloodstream infection (31%) and urinary tract infections (13%)37. The increasing resistance of 265 
such gram-negative bacteria towards different antibiotics further worsens the situation, especially 266 
where the emergence of new AR is outcompeting development of new antibiotics40. 267 
The burden of AR continues to increase and is as a major threat to the public health, 268 
especially the treatment of infectious disease41. Data herein show ARB and ARGs in hospital 269 
wastewaters in New Delhi pose a particular health risk because they include extremely MDR 270 
phenotypes, including “untreatable” pathogens. We suspect high levels are due to hospital 271 
overuse of critical antibiotics, overcrowding, and generally ineffective hospital wastewater 272 
treatment plants. As such, to reduce health risk, it is crucial more prudent hospital (and wider) 273 
antibiotic use be adopted, although installing and maintaining more effective hospital wastewater 274 
treatment systems also is needed. Treatment options that better target ARB and ARGs, including 275 
secondary and tertiary wastewater technologies, are needed as well as strategies for reducing 276 
HGT to environmental strains42. Characterizing hospital wastes herein is an important starting 277 
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point for interventions, but use must be reduced and waste management improved in reduce AR 278 
spread, especially in places like New Delhi without a fully developed urban wastewater 279 
infrastructure.  280 
 281 
Supporting Information 282 
Additional information has been provided online, including: a list of hospitals where wastewater 283 
samples were collected (Table S1); water quality conditions for samples collected from hospitals 284 
and community drains (Table S2); primers for target genes in PCR and qPCR (Table S3); design 285 
discharge levels from hospital wastewater treatment plants and community drains (Table S4); 286 
detailed abundance data on TC, FC, and ESBL-resistant and CRE bacteria in wastewater  287 
samples from the hospitals in the summer and winter (Table S5); abundances of 16S-rDNA 288 
genes, blaNDM-1, blaCTX, blaOXA, blaTEM and int1 in hospital wastewater samples in the summer 289 
and winter (Table S6); abundances of TC, FC, and ESBL-resistant and CRE bacteria in sewer 290 
drain samples in the summer and winter (Table S7); abundances of blaNDM-1, blaCTX, blaOXA and 291 
blaTEM in sewer drain samples in the summer and winter (Table S8); and accession numbers for 292 
CRE isolates from this study (Table S9). Also included are figures displaying the following: 293 
relationships between ESBL-resistant bacteria and FC levels, and the relative abundance of 294 
blaCTX, blaOXA and blaTEM, in hospital wastewaters (Figure S1); relationships between int1 gene 295 
abundances, and FC and blaNDM-1 levels in hospital wastewaters (Figure S2); relationships 296 
between blaNDM-1 and 16S-rRNA gene levels in hospital wastewaters (Figure S3); and 297 
proportional abundances of ESBL-resistant isolates as a function of hospital size in the hospital 298 
wastewaters (Figure S4).  299 
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Figure Legends 432 
Figure 1 Relationships between carbapenem-resistant Enterobacteriaceae (CRE), blaNDM-1 433 
abundance, ESBL-resistant bacteria (ESBL), and total coliform bacteria (TC), and fecal coliform 434 
bacterial levels in hospital wastewater outfalls from across New Delhi.  435 
Figure 2 Concentration of FC, CRE, blaNDM-1, int1 in wastewaters from each New Delhi 436 
hospital. Data normalized to patient number. Error bars refer to standard errors. 437 
Figure 3 Abundance of faecal coliforms, CRE, blaNDM-1 and int1 in wastewaters from large 438 
(n=6) and small (n=6) hospitals in New Delhi in winter samples. *Statistically significant 439 
difference (Paired t-test; CRE and blaNDM-1, p = 0.009; Faecal Coliforms, p = 0.046). Boxes 440 
represent the 25 to 75% percentile range and bars represent the standard error.  441 
Figure 4 Proportional abundance of CRE bacteria as a function of genus and hospital sizes in 442 
hospital wastewaters across New Delhi. Data reported per wastewater volume basis. Small 443 
hospital CRE isolates, n = 494; Large hospital CRE isolates, n = 953.  444 
 445 
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Hospital wastes seed carbapenem-resistance  
pathogens to Indian urban water systems 
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